Keun Seok Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keun Seok Seo has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Joo Youn Park
Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi, USA
14 shared publicationsYong Ho Park
Department of Microbiology, BK21 Program for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea
14 shared publicationsNogi Park
Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University
10 shared publicationsGregory A. Bohach
Department of Microbiology, Molecular Biology, and Biochemistry; University of Idaho; Moscow ID 83844
9 shared publications- Joo Youn Park
Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS 39762, USA
8 shared publications Justin A. Thornton
Department of Biological Sciences, College of Arts and Sciences, Mississippi State University, Mississippi State, Mississippi, USA
7 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11)
An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development
Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve tissue engineering has introduced resorbable scaffolds that can develop into stable, functional tissue. In each case, an increasing breadth of strategies is being developed to curb the persistent issue of valve deterioration. This study aimed to synthesize and characterize an ascorbic acid‐containing polyurethane to impart antioxidant properties to degradable scaffolds for tissue engineered heart valve (TEHV) replacement. Blends of poly(carbonate‐ascorbic acid) urethane (PCAU) and poly(carbonate urethane) urea (PCUU) were fabricated into microporous scaffolds to evaluate the impact of PCAU in vitro on mechanics, degradation, cell viability, calcification, bacterial adhesion, and in vivo on native tissue response in a juvenile rat subcutaneous model. PCAU blended with PCUU in a 25:75 ratio (PCAU‐25) had mechanical properties similar to PCUU, while higher concentrations of PCAU were not mechanically robust. PCAU‐25 showed greater reactive oxygen species (ROS) inhibition and degradation, and reduced calcification and bacterial adhesion in vitro. In a juvenile rat subcutaneous model, both PCUU and PCAU‐25 groups showed negligible calcification after 4 weeks. PCAU‐25, however, showed much greater cell infiltration and immune response, possibly due to an accelerated rate of degradation. PCAU‐25 was then fabricated into a polymeric valve scaffold and underwent basic mechanical and hydrodynamic performance assessment that demonstrated function similar to PCUU valves previously reported. These findings demonstrate proof‐of‐concept for a new polyurethane formulation incorporating ascorbic acid for antioxidant bioactivity and translatability into a functional TEHV scaffold.
- 21 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (11)
Open AccessAn Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development
Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve tissue engineering has introduced resorbable scaffolds that can develop into stable, functional tissue. In each case, an increasing breadth of strategies is being developed to curb the persistent issue of valve deterioration. This study aimed to synthesize and characterize an ascorbic acid‐containing polyurethane to impart antioxidant properties to degradable scaffolds for tissue engineered heart valve (TEHV) replacement. Blends of poly(carbonate‐ascorbic acid) urethane (PCAU) and poly(carbonate urethane) urea (PCUU) were fabricated into microporous scaffolds to evaluate the impact of PCAU in vitro on mechanics, degradation, cell viability, calcification, bacterial adhesion, and in vivo on native tissue response in a juvenile rat subcutaneous model. PCAU blended with PCUU in a 25:75 ratio (PCAU‐25) had mechanical properties similar to PCUU, while higher concentrations of PCAU were not mechanically robust. PCAU‐25 showed greater reactive oxygen species (ROS) inhibition and degradation, and reduced calcification and bacterial adhesion in vitro. In a juvenile rat subcutaneous model, both PCUU and PCAU‐25 groups showed negligible calcification after 4 weeks. PCAU‐25, however, showed much greater cell infiltration and immune response, possibly due to an accelerated rate of degradation. PCAU‐25 was then fabricated into a polymeric valve scaffold and underwent basic mechanical and hydrodynamic performance assessment that demonstrated function similar to PCUU valves previously reported. These findings demonstrate proof‐of‐concept for a new polyurethane formulation incorporating ascorbic acid for antioxidant bioactivity and translatability into a functional TEHV scaffold.
- Open Access
- 26 May 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (5) , e0023226
Identification of the Annexin A2-interacting domain of pneumococcal PsaA
Streptococcus pneumoniae is a gram-positive bacterium, colonizer of the human nasopharynx capable of causing severe invasive disease. Colonization of the nasopharynx is a prerequisite for the development of invasive disease and depends upon surface-bound bacterial proteins interacting with host cell receptors. Pneumococcal surface adhesin A (PsaA) is a highly conserved lipoprotein involved in the attachment to host airway cells via the host receptor Annexin A2 (ANXA2). However, the specific structural domains of PsaA responsible for ANXA2 recognition and binding remain unknown. Here, we employed a structure-based peptide approach to map the ANXA2-binding domain of PsaA. Five recombinant PsaA peptides were designed and generated based on the crystal structure of PsaA. Far-western blot analysis using ANXA2-overexpressing HEK293T/17 cell lysates revealed that the interaction with ANXA2 was specific to the C-terminal subdomain of PsaA. Cell-binding assays and flow cytometry further confirmed the interaction between the C-terminal subdomain of PsaA and cell surface-expressed ANXA2. Furthermore, polyclonal antibodies against the C-terminal subdomain significantly inhibited the binding of full-length PsaA to ANXA2-overexpressing cells, whereas antibodies against other subdomains did not. Consistently, polyclonal antibodies against the C-terminus of PsaA reduced the binding of S. pneumoniae to A549 lung epithelial cells to a greater extent than other antibodies. Together, these findings establish that the C-terminus of PsaA is crucial for ANXA2 receptor recognition. Targeting this specific subdomain may be a promising strategy for developing next-generation protein-based pneumococcal vaccines that aim at blocking bacterial adherence. IMPORTANCE: Streptococcus pneumoniae is a leading cause of millions of deaths worldwide each year due to its ability to transition from an asymptomatic colonizer to an invasive pathogen. Current pneumococcal conjugate and polysaccharide vaccines protect against pneumococcal disease, but overall colonization rates have remained stable. Since pneumococcus is an opportunistic pathogen, decreasing overall colonization rates is essential for preventing progression to disease. The significance of our research lies in mapping functional epitopes within key pneumococcal adhesins that play a critical role in bacterial adherence. Defining these adhesion epitopes is essential for the rational design of next-generation protein-based vaccines capable of blocking colonization and ultimately reducing the global burden of invasive pneumococcal diseases.
- 26 May 2026
- Published by American Society for Microbiology in mSphere
- Vol. 11 (5) , e0023226
Open AccessIdentification of the Annexin A2-interacting domain of pneumococcal PsaA
Streptococcus pneumoniae is a gram-positive bacterium, colonizer of the human nasopharynx capable of causing severe invasive disease. Colonization of the nasopharynx is a prerequisite for the development of invasive disease and depends upon surface-bound bacterial proteins interacting with host cell receptors. Pneumococcal surface adhesin A (PsaA) is a highly conserved lipoprotein involved in the attachment to host airway cells via the host receptor Annexin A2 (ANXA2). However, the specific structural domains of PsaA responsible for ANXA2 recognition and binding remain unknown. Here, we employed a structure-based peptide approach to map the ANXA2-binding domain of PsaA. Five recombinant PsaA peptides were designed and generated based on the crystal structure of PsaA. Far-western blot analysis using ANXA2-overexpressing HEK293T/17 cell lysates revealed that the interaction with ANXA2 was specific to the C-terminal subdomain of PsaA. Cell-binding assays and flow cytometry further confirmed the interaction between the C-terminal subdomain of PsaA and cell surface-expressed ANXA2. Furthermore, polyclonal antibodies against the C-terminal subdomain significantly inhibited the binding of full-length PsaA to ANXA2-overexpressing cells, whereas antibodies against other subdomains did not. Consistently, polyclonal antibodies against the C-terminus of PsaA reduced the binding of S. pneumoniae to A549 lung epithelial cells to a greater extent than other antibodies. Together, these findings establish that the C-terminus of PsaA is crucial for ANXA2 receptor recognition. Targeting this specific subdomain may be a promising strategy for developing next-generation protein-based pneumococcal vaccines that aim at blocking bacterial adherence. IMPORTANCE: Streptococcus pneumoniae is a leading cause of millions of deaths worldwide each year due to its ability to transition from an asymptomatic colonizer to an invasive pathogen. Current pneumococcal conjugate and polysaccharide vaccines protect against pneumococcal disease, but overall colonization rates have remained stable. Since pneumococcus is an opportunistic pathogen, decreasing overall colonization rates is essential for preventing progression to disease. The significance of our research lies in mapping functional epitopes within key pneumococcal adhesins that play a critical role in bacterial adherence. Defining these adhesion epitopes is essential for the rational design of next-generation protein-based vaccines capable of blocking colonization and ultimately reducing the global burden of invasive pneumococcal diseases.
- Open Access
- 2 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11659
Do Food Preservatives Affect Staphylococcal Enterotoxin C Production Equally?
Staphylococcal enterotoxins (SEs), particularly enterotoxin C (SEC), are potent superantigens primarily known for causing food poisoning, but recent studies have highlighted their potential role in immune-mediated intestinal diseases. Despite the widespread use of food preservatives, their influence on SEC production—especially from coagulase-negative staphylococci (CNS)—remains poorly understood. In this study, we evaluated the effects of commonly used preservatives, including sodium chloride, potassium nitrate, and sorbic acid, on the expression and production of SEC3 and SECepi in Staphylococcus aureus and S. epidermidis, respectively. Using ELISA and RT-qPCR, we analyzed toxin levels at both the protein and mRNA levels. Proliferation assays on human PBMCs assessed the mitogenic potential of culture supernatants. While sodium chloride and potassium nitrate did not significantly alter SEC levels or bacterial growth, only sorbic acid at 0.07% consistently inhibited both mRNA expression and protein production of SEC3 and SECepi. Furthermore, supernatants from sorbic acid-treated cultures induced significantly lower PBMC proliferation. These results suggest that even sub-emetic concentrations of enterotoxins may have immunomodulatory effects, and sorbic acid could be a promising agent in mitigating such risks.
- 2 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11659
Open AccessDo Food Preservatives Affect Staphylococcal Enterotoxin C Production Equally?
Staphylococcal enterotoxins (SEs), particularly enterotoxin C (SEC), are potent superantigens primarily known for causing food poisoning, but recent studies have highlighted their potential role in immune-mediated intestinal diseases. Despite the widespread use of food preservatives, their influence on SEC production—especially from coagulase-negative staphylococci (CNS)—remains poorly understood. In this study, we evaluated the effects of commonly used preservatives, including sodium chloride, potassium nitrate, and sorbic acid, on the expression and production of SEC3 and SECepi in Staphylococcus aureus and S. epidermidis, respectively. Using ELISA and RT-qPCR, we analyzed toxin levels at both the protein and mRNA levels. Proliferation assays on human PBMCs assessed the mitogenic potential of culture supernatants. While sodium chloride and potassium nitrate did not significantly alter SEC levels or bacterial growth, only sorbic acid at 0.07% consistently inhibited both mRNA expression and protein production of SEC3 and SECepi. Furthermore, supernatants from sorbic acid-treated cultures induced significantly lower PBMC proliferation. These results suggest that even sub-emetic concentrations of enterotoxins may have immunomodulatory effects, and sorbic acid could be a promising agent in mitigating such risks.
- Open Access
- 14 March 2025
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 4 (4) , 320-335
A new sequential dual flow lab-on-a-chip with a lyophilized one-component chemiluminescence substrate for high-sensitive microchannel lateral flow assay (mLFA)
Recently, there has been a growing demand for the development of lab-on-a-chip (LOC) platforms with new assays and detection protocols for point-of-care-test (POCT) applications. So far, chemiluminescence (CL) detection-based immunoassays have shown promising performance for the high-sensitive POCT, but they require automated machines or multiple manual steps to perform the CL-based assay. In this work, a fully automated CL-based immunoassay was developed using a new sequential dual flow LOC with on-chip lyophilized CL substrate, and then a highly specific and sensitive immunoassay using a pair of single chain variable fragment (scFv) capture and detection antibodies was successfully performed. The concept of sequential and automatic control of dual flows, which was strongly desired for ensuring that the reconstituted detection antibody conjugated with horseradish peroxidase flowed first through the reaction zones and then the reconstituted CL substrate flowed, was newly developed and implemented on the LOC. In addition, a new one-component CL substrate in liquid format was introduced and lyophilized for the on-chip lyophilized substrate, developing a new lyophilization process. To evaluate the assay performance on the developed new LOC platform, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was chosen as a demonstration vehicle. The nucleocapsid (N) protein of SARS-CoV-2 was analyzed using the custom-developed scFv antibody pair from a phage display library system, which showed a better limit of detection (LoD) over the commercially available rapid diagnostic test (RDT) kits for detecting SARS-CoV-2. Finally, a portable reader for reading the CL signal from the CL-based microchannel lateral flow assay (CL-mLFA) was developed and used for evaluating the performance of the SARS-CoV-2 assay on the developed LOC platform. An LoD of approximately 1.6 ng mL−1 was achieved, which was acceptable for the early diagnosis of SARS-CoV-2 infection. The new CL-mLFA platform developed in this work, adopting the sequential dual flow LOC and the lyophilized one-component CL substrate, can be applied to other high-sensitive immunoassays in POCT for diagnosing various chronic or infectious diseases.
- 14 March 2025
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 4 (4) , 320-335
Open AccessA new sequential dual flow lab-on-a-chip with a lyophilized one-component chemiluminescence substrate for high-sensitive microchannel lateral flow assay (mLFA)
Recently, there has been a growing demand for the development of lab-on-a-chip (LOC) platforms with new assays and detection protocols for point-of-care-test (POCT) applications. So far, chemiluminescence (CL) detection-based immunoassays have shown promising performance for the high-sensitive POCT, but they require automated machines or multiple manual steps to perform the CL-based assay. In this work, a fully automated CL-based immunoassay was developed using a new sequential dual flow LOC with on-chip lyophilized CL substrate, and then a highly specific and sensitive immunoassay using a pair of single chain variable fragment (scFv) capture and detection antibodies was successfully performed. The concept of sequential and automatic control of dual flows, which was strongly desired for ensuring that the reconstituted detection antibody conjugated with horseradish peroxidase flowed first through the reaction zones and then the reconstituted CL substrate flowed, was newly developed and implemented on the LOC. In addition, a new one-component CL substrate in liquid format was introduced and lyophilized for the on-chip lyophilized substrate, developing a new lyophilization process. To evaluate the assay performance on the developed new LOC platform, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was chosen as a demonstration vehicle. The nucleocapsid (N) protein of SARS-CoV-2 was analyzed using the custom-developed scFv antibody pair from a phage display library system, which showed a better limit of detection (LoD) over the commercially available rapid diagnostic test (RDT) kits for detecting SARS-CoV-2. Finally, a portable reader for reading the CL signal from the CL-based microchannel lateral flow assay (CL-mLFA) was developed and used for evaluating the performance of the SARS-CoV-2 assay on the developed LOC platform. An LoD of approximately 1.6 ng mL−1 was achieved, which was acceptable for the early diagnosis of SARS-CoV-2 infection. The new CL-mLFA platform developed in this work, adopting the sequential dual flow LOC and the lyophilized one-component CL substrate, can be applied to other high-sensitive immunoassays in POCT for diagnosing various chronic or infectious diseases.
- Open Access
- 26 March 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (3) , e0077423
L-arginine supplementation abrogates hypoxia-induced virulence of Staphylococcus aureus in a murine diabetic pressure wound model
Diabetic foot ulcers (DFUs) are the most common complications of diabetes resulting from hyperglycemia leading to ischemic hypoxic tissue and nerve damage. Staphylococcus aureus is the most frequently isolated bacteria from DFUs and causes severe necrotic infections leading to amputations with a poor 5-year survival rate. However, very little is known about the mechanisms by which S. aureus dominantly colonizes and causes severe disease in DFUs. Herein, we utilized a pressure wound model in diabetic TALLYHO/JngJ mice to reproduce ischemic hypoxic tissue damage seen in DFUs and demonstrated that anaerobic fermentative growth of S. aureus significantly increased the virulence and the severity of disease by activating two-component regulatory systems leading to expression of virulence factors. Our in vitro studies showed that supplementation of nitrate as a terminal electron acceptor promotes anaerobic respiration and suppresses the expression of S. aureus virulence factors through inactivation of two-component regulatory systems, suggesting potential therapeutic benefits by promoting anaerobic nitrate respiration. Our in vivo studies revealed that dietary supplementation of L-arginine (L-Arg) significantly attenuated the severity of disease caused by S. aureus in the pressure wound model by providing nitrate. Collectively, these findings highlight the importance of anaerobic fermentative growth in S. aureus pathogenesis and the potential of dietary L-Arg supplementation as a therapeutic to prevent severe S. aureus infection in DFUs. IMPORTANCE: S. aureus is the most common cause of infection in DFUs, often resulting in lower-extremity amputation with a distressingly poor 5-year survival rate. Treatment for S. aureus infections has largely remained unchanged for decades and involves tissue debridement with antibiotic therapy. With high levels of conservative treatment failure, recurrence of ulcers, and antibiotic resistance, a new approach is necessary to prevent lower-extremity amputations. Nutritional aspects of DFU treatment have largely been overlooked as there has been contradictory clinical trial evidence, but very few in vitro and in vivo modelings of nutritional treatment studies have been performed. Here we demonstrate that dietary supplementation of L-Arg in a diabetic mouse model significantly reduced duration and severity of disease caused by S. aureus . These findings suggest that L-Arg supplementation could be useful as a potential preventive measure against severe S. aureus infections in DFUs.
- 26 March 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (3) , e0077423
Open AccessL-arginine supplementation abrogates hypoxia-induced virulence of Staphylococcus aureus in a murine diabetic pressure wound model
Diabetic foot ulcers (DFUs) are the most common complications of diabetes resulting from hyperglycemia leading to ischemic hypoxic tissue and nerve damage. Staphylococcus aureus is the most frequently isolated bacteria from DFUs and causes severe necrotic infections leading to amputations with a poor 5-year survival rate. However, very little is known about the mechanisms by which S. aureus dominantly colonizes and causes severe disease in DFUs. Herein, we utilized a pressure wound model in diabetic TALLYHO/JngJ mice to reproduce ischemic hypoxic tissue damage seen in DFUs and demonstrated that anaerobic fermentative growth of S. aureus significantly increased the virulence and the severity of disease by activating two-component regulatory systems leading to expression of virulence factors. Our in vitro studies showed that supplementation of nitrate as a terminal electron acceptor promotes anaerobic respiration and suppresses the expression of S. aureus virulence factors through inactivation of two-component regulatory systems, suggesting potential therapeutic benefits by promoting anaerobic nitrate respiration. Our in vivo studies revealed that dietary supplementation of L-arginine (L-Arg) significantly attenuated the severity of disease caused by S. aureus in the pressure wound model by providing nitrate. Collectively, these findings highlight the importance of anaerobic fermentative growth in S. aureus pathogenesis and the potential of dietary L-Arg supplementation as a therapeutic to prevent severe S. aureus infection in DFUs. IMPORTANCE: S. aureus is the most common cause of infection in DFUs, often resulting in lower-extremity amputation with a distressingly poor 5-year survival rate. Treatment for S. aureus infections has largely remained unchanged for decades and involves tissue debridement with antibiotic therapy. With high levels of conservative treatment failure, recurrence of ulcers, and antibiotic resistance, a new approach is necessary to prevent lower-extremity amputations. Nutritional aspects of DFU treatment have largely been overlooked as there has been contradictory clinical trial evidence, but very few in vitro and in vivo modelings of nutritional treatment studies have been performed. Here we demonstrate that dietary supplementation of L-Arg in a diabetic mouse model significantly reduced duration and severity of disease caused by S. aureus . These findings suggest that L-Arg supplementation could be useful as a potential preventive measure against severe S. aureus infections in DFUs.
- Open Access
- 18 December 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 212 (3) , 421-432
Stimulation Strength Determined by Superantigen Dose Controls Subcellular Localization of FOXP3 Isoforms and Suppressive Function of CD4+CD25+FOXP3+ T Cells
Staphylococcal superantigens induce massive activation of T cells and inflammation, leading to toxic shock syndrome. Paradoxically, increasing evidence indicates that superantigens can also induce immunosuppression by promoting regulatory T cell (Treg) development. In this study, we demonstrate that stimulation strength plays a critical role in superantigen-mediated induction of immunosuppressive human CD4+CD25+FOXP3+ T cells. Suboptimal stimulation by a low dose (1 ng/ml) of staphylococcal enterotoxin C1 (SEC1) led to de novo generation of Treg-like CD4+CD25+FOXP3+ T cells with strong suppressive activity. In contrast, CD4+CD25+ T cells induced by optimal stimulation with high-dose SEC1 (1 µg/ml) were not immunosuppressive, despite high FOXP3 expression. Signal transduction pathway analysis revealed differential activation of the PI3K signaling pathway and expression of PTEN in optimal and suboptimal stimulation with SEC1. Additionally, we identified that FOXP3 isoforms in Treg-like cells from the suboptimal condition were located in the nucleus, whereas FOXP3 in nonsuppressive cells from the optimal condition localized in cytoplasm. Sequencing analysis of FOXP3 isoform transcripts identified five isoforms, including a FOXP3 isoform lacking partial exon 3. Overexpression of FOXP3 isoforms confirmed that both an exon 2–lacking isoform and a partial exon 3–lacking isoform confer suppressive activity. Furthermore, blockade of PI3K in optimal stimulation conditions led to induction of suppressive Treg-like cells with nuclear translocation of FOXP3, suggesting that PI3K signaling impairs induction of Tregs in a SEC1 dose-dependent manner. Taken together, these data demonstrate that the strength of activation signals determined by superantigen dose regulates subcellular localization of FOXP3 isoforms, which confers suppressive functionality.
- 18 December 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 212 (3) , 421-432
Open AccessStimulation Strength Determined by Superantigen Dose Controls Subcellular Localization of FOXP3 Isoforms and Suppressive Function of CD4+CD25+FOXP3+ T Cells
Staphylococcal superantigens induce massive activation of T cells and inflammation, leading to toxic shock syndrome. Paradoxically, increasing evidence indicates that superantigens can also induce immunosuppression by promoting regulatory T cell (Treg) development. In this study, we demonstrate that stimulation strength plays a critical role in superantigen-mediated induction of immunosuppressive human CD4+CD25+FOXP3+ T cells. Suboptimal stimulation by a low dose (1 ng/ml) of staphylococcal enterotoxin C1 (SEC1) led to de novo generation of Treg-like CD4+CD25+FOXP3+ T cells with strong suppressive activity. In contrast, CD4+CD25+ T cells induced by optimal stimulation with high-dose SEC1 (1 µg/ml) were not immunosuppressive, despite high FOXP3 expression. Signal transduction pathway analysis revealed differential activation of the PI3K signaling pathway and expression of PTEN in optimal and suboptimal stimulation with SEC1. Additionally, we identified that FOXP3 isoforms in Treg-like cells from the suboptimal condition were located in the nucleus, whereas FOXP3 in nonsuppressive cells from the optimal condition localized in cytoplasm. Sequencing analysis of FOXP3 isoform transcripts identified five isoforms, including a FOXP3 isoform lacking partial exon 3. Overexpression of FOXP3 isoforms confirmed that both an exon 2–lacking isoform and a partial exon 3–lacking isoform confer suppressive activity. Furthermore, blockade of PI3K in optimal stimulation conditions led to induction of suppressive Treg-like cells with nuclear translocation of FOXP3, suggesting that PI3K signaling impairs induction of Tregs in a SEC1 dose-dependent manner. Taken together, these data demonstrate that the strength of activation signals determined by superantigen dose regulates subcellular localization of FOXP3 isoforms, which confers suppressive functionality.
- Open Access
- 5 December 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (50)
Multiclonal human origin and global expansion of an endemic bacterial pathogen of livestock
Most new pathogens of humans and animals arise via switching events from distinct host species. However, our understanding of the evolutionary and ecological drivers of successful host adaptation, expansion, and dissemination are limited.Staphylococcus aureusis a major bacterial pathogen of humans and a leading cause of mastitis in dairy cows worldwide. Here we trace the evolutionary history of bovineS. aureususing a global dataset of 10,254S. aureusgenomes including 1,896 bovine isolates from 32 countries in 6 continents. We identified 7 major contemporary endemic clones ofS. aureuscausing bovine mastitis around the world and traced them back to 4 independent host-jump events from humans that occurred up to 2,500 y ago. Individual clones emerged and underwent clonal expansion from the mid-19th to late 20th century coinciding with the commercialization and industrialization of dairy farming, and older lineages have become globally distributed via established cattle trade links. Importantly, we identified lineage-dependent differences in the frequency of host transmission events between humans and cows in both directions revealing high risk clones threatening veterinary and human health. Finally, pangenome network analysis revealed that some bovineS. aureuslineages contained distinct sets of bovine-associated genes, consistent with multiple trajectories to host adaptation via gene acquisition. Taken together, we have dissected the evolutionary history of a major endemic pathogen of livestock providing a comprehensive temporal, geographic, and gene-level perspective of its remarkable success.
- 5 December 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (50)
Open AccessMulticlonal human origin and global expansion of an endemic bacterial pathogen of livestock
Most new pathogens of humans and animals arise via switching events from distinct host species. However, our understanding of the evolutionary and ecological drivers of successful host adaptation, expansion, and dissemination are limited.Staphylococcus aureusis a major bacterial pathogen of humans and a leading cause of mastitis in dairy cows worldwide. Here we trace the evolutionary history of bovineS. aureususing a global dataset of 10,254S. aureusgenomes including 1,896 bovine isolates from 32 countries in 6 continents. We identified 7 major contemporary endemic clones ofS. aureuscausing bovine mastitis around the world and traced them back to 4 independent host-jump events from humans that occurred up to 2,500 y ago. Individual clones emerged and underwent clonal expansion from the mid-19th to late 20th century coinciding with the commercialization and industrialization of dairy farming, and older lineages have become globally distributed via established cattle trade links. Importantly, we identified lineage-dependent differences in the frequency of host transmission events between humans and cows in both directions revealing high risk clones threatening veterinary and human health. Finally, pangenome network analysis revealed that some bovineS. aureuslineages contained distinct sets of bovine-associated genes, consistent with multiple trajectories to host adaptation via gene acquisition. Taken together, we have dissected the evolutionary history of a major endemic pathogen of livestock providing a comprehensive temporal, geographic, and gene-level perspective of its remarkable success.
- Open Access
- 26 October 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (5) , e0178122
The Group B Streptococcal Adhesin BspC Interacts with Host Cytokeratin 19 To Promote Colonization of the Female Reproductive Tract
Group BStreptococcus(GBS) asymptomatically colonizes the female reproductive tract (FRT) of up to one third of women, but GBS carriage can lead to adverse pregnancy outcomes, including premature rupture of membranes, preterm labor, and chorioamnionitis. GBS colonization during pregnancy is also the largest predisposing factor for neonatal GBS disease, including pneumonia, sepsis, and meningitis.
- 26 October 2022
- Published by American Society for Microbiology in mBio
- Vol. 13 (5) , e0178122
Open AccessThe Group B Streptococcal Adhesin BspC Interacts with Host Cytokeratin 19 To Promote Colonization of the Female Reproductive Tract
Group BStreptococcus(GBS) asymptomatically colonizes the female reproductive tract (FRT) of up to one third of women, but GBS carriage can lead to adverse pregnancy outcomes, including premature rupture of membranes, preterm labor, and chorioamnionitis. GBS colonization during pregnancy is also the largest predisposing factor for neonatal GBS disease, including pneumonia, sepsis, and meningitis.
- Open Access
- 7 July 2022
- Published by MDPI AG in Biomimetics
- Vol. 7 (3) , 91
Effect of Treated Time of Hydrothermal Etching Process on Oxide Layer Formation and Its Antibacterial Properties
Inspired by natural materials, we developed an antibacterial surface on titanium (Ti) using hydrothermal etching techniques and examined the effect of treated time on oxide layer formation, its antibacterial properties, and surface defects. Hydrothermal etching was conducted on Grade 2 commercially pure Ti immersed in 5M NaOH at 250 °C during a range of time of 0–12 h. Nanopillars generated on the surface had ~100 nm thickness, which resulted in decreased attachment and rupturing of the attached bacteria. The results also showed that 6 h and 8 h of etching time provided a desirable uniform nanopillar structure with the most effective prevention of bacterial adherence on the surface. Multiscale SEM observations revealed that the longer the etching was conducted, the more cracks propagated, which led to an increase in dissociated fragments of the oxide layer. In the 12 h of etching, a higher density of bacterial adherence was observed than that of the untreated and the shorter time treated samples, indicating that etching took longer than 10 h worsened the antibacterial properties of the nano-patterned surface of Ti. This study demonstrated that the optimal time duration is 6–8 h for the oxide layer formation to maximize antibacterial activity and minimize cracking formation on the surface. For future studies, we suggest exploring many possible conditions to generate a more uniform nanopattern without structural defects to secure the integration between a newly deposited oxide layer and the substrate.
- 7 July 2022
- Published by MDPI AG in Biomimetics
- Vol. 7 (3) , 91
Open AccessEffect of Treated Time of Hydrothermal Etching Process on Oxide Layer Formation and Its Antibacterial Properties
Inspired by natural materials, we developed an antibacterial surface on titanium (Ti) using hydrothermal etching techniques and examined the effect of treated time on oxide layer formation, its antibacterial properties, and surface defects. Hydrothermal etching was conducted on Grade 2 commercially pure Ti immersed in 5M NaOH at 250 °C during a range of time of 0–12 h. Nanopillars generated on the surface had ~100 nm thickness, which resulted in decreased attachment and rupturing of the attached bacteria. The results also showed that 6 h and 8 h of etching time provided a desirable uniform nanopillar structure with the most effective prevention of bacterial adherence on the surface. Multiscale SEM observations revealed that the longer the etching was conducted, the more cracks propagated, which led to an increase in dissociated fragments of the oxide layer. In the 12 h of etching, a higher density of bacterial adherence was observed than that of the untreated and the shorter time treated samples, indicating that etching took longer than 10 h worsened the antibacterial properties of the nano-patterned surface of Ti. This study demonstrated that the optimal time duration is 6–8 h for the oxide layer formation to maximize antibacterial activity and minimize cracking formation on the surface. For future studies, we suggest exploring many possible conditions to generate a more uniform nanopattern without structural defects to secure the integration between a newly deposited oxide layer and the substrate.
- Open Access
- 31 October 2021
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 9 (2) , e0085721
Role of Glucose-6-Phosphate in Metabolic Adaptation of Staphylococcus aureus in Diabetes
Sugars are essential nutrients for S. aureus to survive and proliferate within the host. Because elevated serum glucose levels are a hallmark of diabetes, most studies have focused on the effect of glucose metabolism, and very little is known regarding the effects of metabolism of other sugars on the pathogenesis of S. aureus in diabetes.
- 31 October 2021
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 9 (2) , e0085721
Open AccessRole of Glucose-6-Phosphate in Metabolic Adaptation of Staphylococcus aureus in Diabetes
Sugars are essential nutrients for S. aureus to survive and proliferate within the host. Because elevated serum glucose levels are a hallmark of diabetes, most studies have focused on the effect of glucose metabolism, and very little is known regarding the effects of metabolism of other sugars on the pathogenesis of S. aureus in diabetes.